All In Biotech

Drug Trial Radar · NCT04476303

A Study to Evaluate the Pharmacokinetics and Safety of BEY2153 in Healthy Participants

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Ascending Dose Phase I Clinical Trial to Evaluate the Safety, Tolerability and Pharmacokinetics of BEY2153 After Oral Administration in Healthy Young and Elderly Male Volunteers.

Last checked: Nov 19, 2026Latest source record: Mar 10, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

88

Actual

Start

Aug 27, 2020

Primary completion

Nov 23, 2021

Study completion Nov 23, 2021

Sponsor

Lead sponsor
BeyondBio Inc.Industry
Sponsor type
Industry
First posted
Jul 20, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Randomized
Model
Sequential
Masking
Double (participant, investigator)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
Male only, from 19 years, up to 80 years
Healthy volunteers
Yes

Summary

As written by the sponsor on the registry.

This is a first in human Phase 1 study to evaluate the safety, tolerability and pharmacokinetics with healthy young and elderly adult male volunteers after receiving single and multiple ascending dose of BEY2153.

Conditions

  • Alzheimer's Disease

Interventions

  • BEY2153Drug

    Capsule

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Maximum observed plasma concentration (Cmax)Time frame: Day 1 to Day 9
  2. Area Under the Curve (AUC)Time frame: Day 1 to Day 9
  3. Apparent terminal elimination half-life (t1/2)Time frame: Day 1 to Day 9
  4. Apparent clearance (CL/F)Time frame: Day 1 to Day 9
  5. Apparent volume of distribution (Vz/F)Time frame: Day 1 to Day 9

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Seoul National University Hospital

    Seoul, South Korea

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.